Correlation Between Neurocrine Biosciences and Viatris
Can any of the company-specific risk be diversified away by investing in both Neurocrine Biosciences and Viatris at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neurocrine Biosciences and Viatris into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neurocrine Biosciences and Viatris, you can compare the effects of market volatilities on Neurocrine Biosciences and Viatris and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neurocrine Biosciences with a short position of Viatris. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neurocrine Biosciences and Viatris.
Diversification Opportunities for Neurocrine Biosciences and Viatris
0.46 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Neurocrine and Viatris is 0.46. Overlapping area represents the amount of risk that can be diversified away by holding Neurocrine Biosciences and Viatris in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Viatris and Neurocrine Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neurocrine Biosciences are associated (or correlated) with Viatris. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Viatris has no effect on the direction of Neurocrine Biosciences i.e., Neurocrine Biosciences and Viatris go up and down completely randomly.
Pair Corralation between Neurocrine Biosciences and Viatris
Given the investment horizon of 90 days Neurocrine Biosciences is expected to generate 5.94 times less return on investment than Viatris. But when comparing it to its historical volatility, Neurocrine Biosciences is 1.36 times less risky than Viatris. It trades about 0.02 of its potential returns per unit of risk. Viatris is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest 1,189 in Viatris on August 31, 2024 and sell it today you would earn a total of 133.00 from holding Viatris or generate 11.19% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Neurocrine Biosciences vs. Viatris
Performance |
| Timeline |
| Neurocrine Biosciences |
| Viatris |
Neurocrine Biosciences and Viatris Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Neurocrine Biosciences and Viatris
The main advantage of trading using opposite Neurocrine Biosciences and Viatris positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neurocrine Biosciences position performs unexpectedly, Viatris can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Viatris will offset losses from the drop in Viatris' long position.| Neurocrine Biosciences vs. Emergent Biosolutions | Neurocrine Biosciences vs. Bausch Health Companies | Neurocrine Biosciences vs. Teva Pharma Industries | Neurocrine Biosciences vs. Haleon plc |
| Viatris vs. Emergent Biosolutions | Viatris vs. Bausch Health Companies | Viatris vs. Neurocrine Biosciences | Viatris vs. Teva Pharma Industries |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Stocks Directory Find actively traded stocks across global markets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |